newsfilter
← Latest News
PR Newswire·

REDUVO™ Marketing Approval on the Right Path

Second Clarifax received from Health Canada.MONTREAL, Dec. 22, 2022 /PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTCQB:TBPMF) (FRA: JAM1) a leader in cannabinoid-derived drug